Yann Chye1, Erynn Christensen1, Murat Yücel1. 1. Brain Mind and Society Research Hub, Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.
Abstract
Objective: Shifting policies and widespread acceptance of cannabis for medical and/or recreational purposes have fueled worries of increased cannabis initiation and use in adolescents. In particular, the adolescent period is thought to be associated with an increased susceptibility to the potential harms of repeated cannabis use, due to being a critical period for neuromaturational events in the brain. This review investigates the neuroimaging evidence of brain harms attributable to adolescent cannabis use. Methods: PubMed and Scopus searches were conducted for empirical articles that examined neuroimaging effects in both adolescent cannabis users and adult user studies that explored the effect of age at cannabis use onset on the brain. Results: We found 43 studies that examined brain effect (structural and functional magnetic resonance imaging) in adolescent cannabis users and 20 that examined the link between onset age of cannabis use and brain effects in adult users. Studies on adolescent cannabis users relative to nonusers mainly implicate frontal and parietal regions and associated brain activation in relation to inhibitory control, reward, and memory. However, studies in adults are more mixed, many of which did not observe an effect of onset age of cannabis use on brain imaging metrics. Conclusions: While there is some evidence of compromised frontoparietal structure and function in adolescent cannabis use, it remains unclear whether the observed effects are specifically attributable to adolescent onset of use or general cannabis use-related factors such as depressive symptoms. The relative contribution of adolescent onset of cannabis use and use chronicity will have to be more comprehensively examined in prospective, longitudinal studies with more rigorous measures of cannabis use (dosage, exposure, dependence, constituent compounds such as the relative cannabinoid levels).
Objective: Shifting policies and widespread acceptance of cannabis for medical and/or recreational purposes have fueled worries of increased cannabis initiation and use in adolescents. In particular, the adolescent period is thought to be associated with an increased susceptibility to the potential harms of repeated cannabis use, due to being a critical period for neuromaturational events in the brain. This review investigates the neuroimaging evidence of brain harms attributable to adolescent cannabis use. Methods: PubMed and Scopus searches were conducted for empirical articles that examined neuroimaging effects in both adolescent cannabis users and adult user studies that explored the effect of age at cannabis use onset on the brain. Results: We found 43 studies that examined brain effect (structural and functional magnetic resonance imaging) in adolescent cannabis users and 20 that examined the link between onset age of cannabis use and brain effects in adult users. Studies on adolescent cannabis users relative to nonusers mainly implicate frontal and parietal regions and associated brain activation in relation to inhibitory control, reward, and memory. However, studies in adults are more mixed, many of which did not observe an effect of onset age of cannabis use on brain imaging metrics. Conclusions: While there is some evidence of compromised frontoparietal structure and function in adolescent cannabis use, it remains unclear whether the observed effects are specifically attributable to adolescent onset of use or general cannabis use-related factors such as depressive symptoms. The relative contribution of adolescent onset of cannabis use and use chronicity will have to be more comprehensively examined in prospective, longitudinal studies with more rigorous measures of cannabis use (dosage, exposure, dependence, constituent compounds such as the relative cannabinoid levels).
Entities:
Keywords:
Cannabis; MRI; addiction; adolescence; neuroimaging; substance use disorder
Authors: Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall Journal: Nat Rev Dis Primers Date: 2021-02-25 Impact factor: 52.329
Authors: Jacqueline-Marie N Ferland; Randall J Ellis; Gregory Rompala; Joseph A Landry; James E Callens; Annie Ly; Micah D Frier; Teddy O Uzamere; Yasmin L Hurd Journal: Mol Psychiatry Date: 2022-03-02 Impact factor: 15.992
Authors: Jarrod M Ellingson; Jesse D Hinckley; J Megan Ross; Joseph P Schacht; L Cinnamon Bidwell; Angela D Bryan; Christian J Hopfer; Paula Riggs; Kent E Hutchison Journal: Curr Behav Neurosci Rep Date: 2021-11-15
Authors: Nora Penzel; Linda A Antonucci; Linda T Betz; Rachele Sanfelici; Johanna Weiske; Oliver Pogarell; Paul Cumming; Boris B Quednow; Oliver Howes; Peter Falkai; Rachel Upthegrove; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Rebekka Lencer; Eva Meisenzahl; Marlene Rosen; Theresa Haidl; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Raimo R K Salokangas; Christos Pantelis; Stephen J Wood; Nikolaos Koutsouleris; Joseph Kambeitz Journal: Neuropsychopharmacology Date: 2021-03-03 Impact factor: 7.853
Authors: Max M Owens; Matthew D Albaugh; Nicholas Allgaier; Dekang Yuan; Gabriel Robert; Renata B Cupertino; Philip A Spechler; Anthony Juliano; Sage Hahn; Tobias Banaschewski; Arun L W Bokde; Sylvane Desrivières; Herta Flor; Antoine Grigis; Penny Gowland; Andreas Heinz; Rüdiger Brühl; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Eric Artiges; Frauke Nees; Dimitri Papadopoulos Orfanos; Herve Lemaitre; Tomáš Paus; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Michael N Smolka; Henrik Walter; Robert Whelan; Scott Mackey; Gunter Schumann; Hugh Garavan Journal: Transl Psychiatry Date: 2022-05-06 Impact factor: 7.989
Authors: Matthew D Albaugh; Jonatan Ottino-Gonzalez; Amanda Sidwell; Claude Lepage; Anthony Juliano; Max M Owens; Bader Chaarani; Philip Spechler; Nicholas Fontaine; Pierre Rioux; Lindsay Lewis; Seun Jeon; Alan Evans; Deepak D'Souza; Rajiv Radhakrishnan; Tobias Banaschewski; Arun L W Bokde; Erin Burke Quinlan; Patricia Conrod; Sylvane Desrivières; Herta Flor; Antoine Grigis; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Frauke Nees; Dimitri Papadopoulos Orfanos; Tomáš Paus; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Michael N Smolka; Henrik Walter; Robert Whelan; Gunter Schumann; Alexandra Potter; Hugh Garavan Journal: JAMA Psychiatry Date: 2021-06-16 Impact factor: 25.911